SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K/A - Current report: [Amend]
SEC Accession No. 0001601830-23-000061
Filing Date
2023-08-11
Accepted
2023-08-11 16:12:59
Documents
12
Period of Report
2023-06-16
Items
Item 5.07: Submission of Matters to a Vote of Security Holders

Document Format Files

Seq Description Document Type Size
1 8-K/A rxrx-20230616.htm   iXBRL 8-K/A 20154
  Complete submission text file 0001601830-23-000061.txt   147227

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT rxrx-20230616.xsd EX-101.SCH 1907
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT rxrx-20230616_lab.xml EX-101.LAB 24833
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT rxrx-20230616_pre.xml EX-101.PRE 13047
6 EXTRACTED XBRL INSTANCE DOCUMENT rxrx-20230616_htm.xml XML 2748
Mailing Address 41S RIO GRANDE STREET SALT LAKE CITY UT 84101
Business Address 41S RIO GRANDE STREET SALT LAKE CITY UT 84101 (385) 269-0203
RECURSION PHARMACEUTICALS, INC. (Filer) CIK: 0001601830 (see all company filings)

IRS No.: 464099738 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K/A | Act: 34 | File No.: 001-40323 | Film No.: 231164231
SIC: 2836 Biological Products, (No Diagnostic Substances)